{"rouge": [{"rouge-1": {"r": 0.2938271604938272, "p": 0.616580310880829, "f": 0.3979933066651939}, "rouge-2": {"r": 0.14654002713704206, "p": 0.3776223776223776, "f": 0.21114369098645144}, "rouge-l": {"r": 0.2839506172839506, "p": 0.5958549222797928, "f": 0.3846153802437892}}], "ozwell": {"s1": "The two notes are very similar. Both describe a 51-year-old woman with a history of well-controlled asthma, allergic rhinitis, and atopic dermatitis, who has been experiencing chronic urticaria for the past three years. They detail her previous unsuccessful treatments with antihistamines and montelukast, and her partial relief with prednisone and cyclosporine, which had side effects. Both notes mention the initiation of omalizumab treatment, which led to significant improvement and allowed her to wean off cyclosporine. They also discuss the patient's initial pruritus controlled with diphenhydramine and the monitoring of her progress. The main difference is the format and some specific details, but the core information is consistent across both notes."}}